#GynCSM Transcript

Healthcare social media transcript of the #GynCSM hashtag.
().
See #GynCSM Influencers/Analytics.

ProfileTweet
GYN Cancer | #GYNCSM @gyncsm
Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
Rick Boulay,MD @journeycancer
RT @gyncsm: You can read over tonight’s #gyncsm topic questions before we get started https://t.co/Ju7prtjUen
Dee Sparacio @womenofteal
RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
GYN Cancer | #GYNCSM @gyncsm
Our co-moderators are @womenofteal @btrfly12 #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 #gyncsm
Annie Ellis @Stigetta
RT @gyncsm: Welcome to #gyncsm - a passionate community of gynecologic cancer survivors, caregivers, advocates and health care providers.
Dee Sparacio @womenofteal
RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Our health care moderators are @ShannonWestin @DrMarkham @journeycancer and our mental health moderator @DrBeckerSchutte #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: Our health care moderators are @ShannonWestin @DrMarkham @journeycancer and our mental health moderator @DrBeckerSchutte #gyncsm
GYN Cancer | #GYNCSM @gyncsm
We start out with 10 min of intro's - Please take a moment to introduce yourself. #gyncsm
Tobey @BRCAinfo
Please excuse the tweet stream. It's time for the #gyncsm chat. Waving hiya ~~~ it's nice to be back learn & support!💕 https://t.co/0xnMuVjczc
Dee Sparacio @womenofteal
RT @gyncsm: We start out with 10 min of intro's - Please take a moment to introduce yourself. #gyncsm
Dee Sparacio @womenofteal
@BRCAinfo Hi there! So glad you are joining us. #gyncsm
Christina Lizaso @btrfly12
Christina Lizaso – passionate re: community engagement and cancer. I’ll be moderating as @gyncsm today. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
Hi all! Gynecologic Oncologist from @mdandersonnews - happy to be here! #gyncsm
Dee Sparacio @womenofteal
@ShannonWestin @mdandersonnews Hello Shannon! #gyncsm
Dee Sparacio @womenofteal
Dee here! Dx #ovca Stage3B 2005, OC research advocate, blogger & co-moderator #gyncsm
GYN Cancer | #GYNCSM @gyncsm
If you prefer to listen only during the chat, we'd love for you to tweet "#gyncsm" when you join just to let us know you are here. #gyncsm
Tobey @BRCAinfo
@womenofteal Thank you #gyncsm
Annie Ellis @Stigetta
Annie Ellis here. I’m a research advocate and 12-yr ovarian cancer survivor currently enjoying a 9-yr third remission #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal Hey Dee! #gyncsm
Robin Martinez @RobinSmrtPtient
Hello, all! Robin here from https://t.co/WC18aFzajs, where #gyncsm members get together to talk in messages of more than 140 characters. :-)
Dee Sparacio @womenofteal
@Stigetta Hi friend and amazing advocate. Glad you can join us. #gyncsm
Rick Boulay,MD @journeycancer
Hey Everyone. Rick Boulay Gyn Onocolgist Allentown PA. I didn't go to SGO this year. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Pls continue intro's & welcomes - we'll start in w/ the "ground rules" :) #gyncsm
Dee Sparacio @womenofteal
@RobinSmrtPtient Waving hi! #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@Stigetta Hi Annie! #gyncsm
GYN Cancer | #GYNCSM @gyncsm
The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Dee Sparacio @womenofteal
@journeycancer Hi Rick #gyncsm
Dee Sparacio @womenofteal
Today's chat is solely informational & not a substitute for speaking w/ a doctor who's familiar w/your medical needs & history. #gyncsm
Annie Ellis @Stigetta
@ShannonWestin Howdy!!! #gyncsm
Dee Sparacio @womenofteal
Remember- Twitter is an open social network & posts are public.Use a DM to exchange email addresses/personal info #gyncsm
Annie Ellis @Stigetta
@womenofteal Hi Dee! #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
Shereese here in Maryland. I'm a Healthcare strategist & policy expert. I didn't attend SGO but am glad to listen in. #gyncsm https://t.co/gQ4upTWu4X
GYN Cancer | #GYNCSM @gyncsm
#gyncsm is not a forum for medical advice. Resources and referrals are provided solely for information and convenience.
Annie Ellis @Stigetta
RT @gyncsm: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Dee Sparacio @womenofteal
@ShereesePubHlth HI Shereese Glad you are here. #gyncsm
Dee Sparacio @womenofteal
#gyncsm community is here 2 support and inform survivors, med workers & loved ones w/ gyn cancer interest
Matthew Katz, MD 🟦 @subatomicdoc
Good evening! Matt Katz, radiation oncologist in MA. I hope you're all well #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@ShereesePubHlth Hi Shereese! #gyncsm
GYN Cancer | #GYNCSM @gyncsm
We also welcome all those “listening in”. You can always tweet us or email us with questions/comments after the chat is over. #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @gyncsm: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Dee Sparacio @womenofteal
@subatomicdoc Hi Matt . Doing Well. Glad to see you #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@womenofteal @journeycancer Hi folks! #gyncsm
Dee Sparacio @womenofteal
Thank you to all who have tweeted during the past month with the #gyncsm hashtag and RT'd about this chat
Diane Radford MD @DianeRadfordMD
RT @btrfly12: Join/Share: Join/Share: SGO Annual Meeting Research Review and ASK the Docs #gyncsm Wed April 12th at 9pmET https://t.co/DALu7D7mKz https://t.co/sChPmD3PS6
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@subatomicdoc Hey Matt!! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@womenofteal Good to see you too! Glad you're well #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Tonight we will discuss the research reported on at the Society of Gynecologic Oncology @SGO_org Annual meeting. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @gyncsm: Tonight we will discuss the research reported on at the Society of Gynecologic Oncology @SGO_org Annual meeting. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm Tonight we will discuss the research reported on at the Society of Gynecologic Oncology @SGO_org Annual meeting. #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@ShannonWestin @ShereesePubHlth Hi ladies! #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: You can read over tonight’s #gyncsm topic questions before we get started https://t.co/Ju7prtjUen
Annie Ellis @Stigetta
RT @gyncsm: Tonight we will discuss the research reported on at the Society of Gynecologic Oncology @SGO_org Annual meeting. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @gyncsm: We also welcome all those “listening in”. You can always tweet us or email us with questions/comments after the chat is over. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
See this link for a listing of all the #gyncsm topic questions that will be coming up: https://t.co/Ju7prtjUen
Dee Sparacio @womenofteal
RT @gyncsm: As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm
Christina Lizaso @btrfly12
RT @gyncsm: See this link for a listing of all the #gyncsm topic questions that will be coming up: See this link for a listing of all the #gyncsm topic questions that will be coming up: https://t.co/Ju7prtjUen
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @gyncsm: As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: The #gyncsm chat promotes community in a public forum. Learn more about risks/benefits: https://t.co/TipZUv1jQy
Dee Sparacio @womenofteal
RT @gyncsm See this link for #gyncsm topic questions: https://t.co/ueeJk5MIaY
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: Pls continue intro's & welcomes - we'll start in w/ the "ground rules" :) #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Here comes our first topic... #gyncsm
Rick Boulay,MD @journeycancer
RT @gyncsm: See this link for a listing of all the #gyncsm topic questions that will be coming up: See this link for a listing of all the #gyncsm topic questions that will be coming up: https://t.co/Ju7prtjUen
GYN Cancer | #GYNCSM @gyncsm
T1: What #SGOMtg presentations did you personally find of most interest? Also, what were some of the "hot topics" of discussion? #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Also, what were some of the "hot topics" of discussion? #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Also, what were some of the "hot topics" of discussion? #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: If you prefer to listen only during the chat, we'd love for you to tweet "#gyncsm" when you join just to let us know you are here. #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm T1What #SGOMtg presentations did you personally find of most interest?what were some of the "hot topics" of discussion? #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Also, what were some of the "hot topics" of discussion? #gyncsm
Annie Ellis @Stigetta
T1: lots of imp news. See my OCRFA SGO report https://t.co/bABRIboozG #gyncsm
Christina Lizaso @btrfly12
T1: Was glad to see the study re: the HPV vaccine dosing - supporting that it can be reduced from 3 doses to 2. #gyncsm
Christina Lizaso @btrfly12
RT @Stigetta: T1: T1: lots of imp news. See my OCRFA SGO report https://t.co/bABRIboozG #gyncsm
Dee Sparacio @womenofteal
Great summary MT @Stigetta T1: See my OCRFA SGO report https://t.co/6yb25RL2nF #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: T1: Was glad to see the study re: T1: Was glad to see the study re: the HPV vaccine dosing - supporting that it can be reduced from 3 doses to 2. #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @ShannonWestin: T1: T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @btrfly12: T1: Was glad to see the study re: T1: Was glad to see the study re: the HPV vaccine dosing - supporting that it can be reduced from 3 doses to 2. #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: See this link for a listing of all the #gyncsm topic questions that will be coming up: See this link for a listing of all the #gyncsm topic questions that will be coming up: https://t.co/Ju7prtjUen
Matthew Katz, MD 🟦 @subatomicdoc
RT @Stigetta: T1: T1: lots of imp news. See my OCRFA SGO report https://t.co/bABRIboozG #gyncsm
Dee Sparacio @womenofteal
@ShannonWestin I agree Niraparib results interested to me https://t.co/B5cdREZkVT #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: As moderator, I'll introduce new Topics with T1, T2... Pls include corresponding T# at front of answer -hard to remember but helpful #gyncsm
Rick Boulay,MD @journeycancer
#gyncsm I heard a lot about the use of PARP inhibitors for consolidation treatment Ovarian cancer treatment. https://t.co/Z4fMCQdXjW
Dee Sparacio @womenofteal
@thathealthsite Hi Justina! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@Stigetta T1 Thanks for the summary! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: T1: T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Tobey @BRCAinfo
@gyncsm Wasn't at #SGOMtg can't wait to hear about it though #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: Tonight we will discuss the research reported on at the Society of Gynecologic Oncology @SGO_org Annual meeting. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal Very interesting to see the activity of #PARPi across all pts regardless of #BRCA status. Strongest effect in #BRCA mutant or HRD #gyncsm
Christina Lizaso @btrfly12
@thathealthsite good to tweet with you again :) #gyncsm
Rick Boulay,MD @journeycancer
RT @btrfly12: T1: Was glad to see the study re: T1: Was glad to see the study re: the HPV vaccine dosing - supporting that it can be reduced from 3 doses to 2. #gyncsm
Tobey @BRCAinfo
RT @Stigetta: T1: T1: lots of imp news. See my OCRFA SGO report https://t.co/bABRIboozG #gyncsm
Tobey @BRCAinfo
RT @btrfly12: T1: Was glad to see the study re: T1: Was glad to see the study re: the HPV vaccine dosing - supporting that it can be reduced from 3 doses to 2. #gyncsm
Tobey @BRCAinfo
RT @ShannonWestin: T1: T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: @womenofteal Very interesting to see the activity of #PARPi across all pts regardless of #BRCA status. Strongest effect in #BRCA mutant or HRD #gyncsm
Robin Martinez @RobinSmrtPtient
Same here, Tobey and Shereese - didn't attend SGO but eager to hear about it. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Topic 2 (T2:) coming up... https://t.co/qZ7zBWS2To #gyncsm
NCI Cancer Stats @NCICancerStats
Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: https://t.co/uWYdgxjsqY #GynCSM
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: @womenofteal Very interesting to see the activity of #PARPi across all pts regardless of #BRCA status. Strongest effect in #BRCA mutant or HRD #gyncsm
Tobey @BRCAinfo
RT @ShannonWestin: @womenofteal Very interesting to see the activity of #PARPi across all pts regardless of #BRCA status. Strongest effect in #BRCA mutant or HRD #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
T1: Sadly, maintenance treatment with taxanes in the upfront setting for #ovariancancer did not improve survival compared to placebo #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @NCICancerStats: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: https://t.co/uWYdgxjsqY #GynCSM
Annie Ellis @Stigetta
T1: Loved Great Debates! Captains @drcarolbrownMSK & @SwisherLiz and their teams were fantastic covering hot topics in gyncancers #gyncsm
Christina Lizaso @btrfly12
T1: Here are some #SGOMtg studies that got a summary article from @cancernetwrk https://t.co/C1k9MOu2XH #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @btrfly12: T1: T1: Here are some #SGOMtg studies that got a summary article from @cancernetwrk https://t.co/C1k9MOu2XH #gyncsm
Dee Sparacio @womenofteal
T1 GOG212 maintenance treatment results surprised me. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal We are of the same mind!!! #disappointed #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@ShannonWestin T1: This is postoperative consolidative chemotherapy? #gyncsm
Christina Lizaso @btrfly12
@thathealthsite I don't think it resolves unfortunately, but should be helpful. Sad to hear about that in Ireland. Rates in U.S. low #gyncsm
Dee Sparacio @womenofteal
@ShannonWestin when I was first dx that is something we talked about. I decided not to do it. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@subatomicdoc Additional 12 months of chemotherapy after the completion of surgery and adjuvant Taxol/carboplatin #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: @subatomicdoc Additional 12 months of chemotherapy after the completion of surgery and adjuvant Taxol/carboplatin #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @btrfly12: T1: T1: Here are some #SGOMtg studies that got a summary article from @cancernetwrk https://t.co/C1k9MOu2XH #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal You were right! #gyncsm
Annie Ellis @Stigetta
T1: Sexual Health Ed Forum w/Don Dizon & Joanne Rush fantastic! tech info + how to talk abt sex & feelings abt talking abt sex #gyncsm
HarveyISinger @UVharvey
RT @ShannonWestin: @womenofteal Very interesting to see the activity of #PARPi across all pts regardless of #BRCA status. Strongest effect in #BRCA mutant or HRD #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Also, what were some of the "hot topics" of discussion? #gyncsm
Dee Sparacio @womenofteal
RT @Stigetta: T1: T1: Sexual Health Ed Forum w/Don Dizon & Joanne Rush fantastic! tech info + how to talk abt sex & feelings abt talking abt sex #gyncsm
Christina Lizaso @btrfly12
T1: @cure_magazine Highlights from #SGOmtg https://t.co/pJS69eKnkR #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T2: Which #SGOMtg studies do you think will most interest patients? Were there findings survivors need to take immediate note of? #gyncsm
Jame Abraham, MD, FACP @jamecancerdoc
Great News for our patients #cancer #PARPI #niraparib https://t.co/ZhnFK1GrFi
Shannon Westin, MD, MPH, FASCO @ShannonWestin
T1/2: Sentinel lymph node mapping in #endometrial and #cervicalcancer was a hot topic at #SGOMtg - great way to reduce side effects! #gyncsm
Tobey @BRCAinfo
RT @btrfly12: T1: T1: @cure_magazine Highlights from #SGOmtg https://t.co/pJS69eKnkR #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@ShannonWestin T1: Sorry to hear it doesn't improve cancer control. But that should mean then less chemo-related toxicity and pursue new approaches #gyncsm
Annie Ellis @Stigetta
@womenofteal @ShannonWestin I also declined taxable maintenance at first remission #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
RT @NCICancerStats: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: https://t.co/uWYdgxjsqY #GynCSM
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: Topic 2 (T2:) coming up... https://t.co/qZ7zBWS2To #gyncsm
Christina Lizaso @btrfly12
@ShannonWestin is Sentinel lymph node mapping a newer thing? have to ask for it thing? only offered some places thing? :) #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: T1/2: T1/2: Sentinel lymph node mapping in #endometrial and #cervicalcancer was a hot topic at #SGOMtg - great way to reduce side effects! #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@subatomicdoc Agree - now is the time for targeted therapy! PARP is getting pushed to the upfront maintenance setting for #ovariancancer #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: T1: T1: @cure_magazine Highlights from #SGOmtg https://t.co/pJS69eKnkR #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T2: T2: Which #SGOMtg studies do you think will most interest patients? Were there findings survivors need to take immediate note of? #gyncsm
HarveyISinger @UVharvey
RT @ShannonWestin: T1: T1: PARP inhibitors for RX of #ovariancancer continue to be a hot topic at #SGOMtg #gyncsm
Dee Sparacio @womenofteal
You can search meeting abstracts > https://t.co/O7EjLiostG #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@btrfly12 It has been growing in use for these two cancers - data are getting stronger now for all to offer - but still need to ask for it! #gyncsm
Christina Lizaso @btrfly12
@Stigetta that is great to hear about sexual health getting coverage - too often a convo skipped #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: You can search meeting abstracts > https://t.co/O7EjLiostG #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @womenofteal: You can search meeting abstracts > https://t.co/O7EjLiostG #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
RT @ShannonWestin: @subatomicdoc Agree - now is the time for targeted therapy! PARP is getting pushed to the upfront maintenance setting for #ovariancancer #gyncsm
Dee Sparacio @womenofteal
T2 Wondering if AXAL in recurrent #cervical cancer will it be effective against all HPV caused cancers or just those from HPV16? #gyncsm
Christina Lizaso @btrfly12
T2: I found this ERAS study of interest - how to make surgery less impactful on quality of life: https://t.co/ul4lYu0h81 #gyncsm
Annie Ellis @Stigetta
@btrfly12 Mechanics have been covered in the past, but this was the first I saw that also covered communication. Very powerful session! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: @btrfly12 It has been growing in use for these two cancers - data are getting stronger now for all to offer - but still need to ask for it! #gyncsm
Annie Ellis @Stigetta
RT @btrfly12: T2: I found this ERAS study of interest - how to make surgery less impactful on quality of life: T2: I found this ERAS study of interest - how to make surgery less impactful on quality of life: https://t.co/ul4lYu0h81 #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
@ShannonWestin @subatomicdoc Agree! PARPs are the new game changers for #ovariancancer with/without #BRCA mutations. #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@ShannonWestin @btrfly12 Do we have randomized trials yet that support it? It took a while in breast cancer #gyncsm
Dee Sparacio @womenofteal
T2 Carbo desensitization highlighted https://t.co/BRLcoQYs1S #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Topic 3 (T3) coming up... #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@btrfly12 We have been using enhanced recovery for the last 2 yrs - it makes a huge difference for pt recovery! better #QOL and pain control #gyncsm
Annie Ellis @Stigetta
RT @LguzzardiM: @ShannonWestin @subatomicdoc Agree! PARPs are the new game changers for #ovariancancer with/without #BRCA mutations. #gyncsm
Dee Sparacio @womenofteal
RT @ShannonWestin: @btrfly12 We have been using enhanced recovery for the last 2 yrs - it makes a huge difference for pt recovery! better #QOL and pain control #gyncsm
SHARE Cancer Support @SHARECancerSupt
@StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: https://t.co/vTLdLbUGhW #gyncsm
SHARE Cancer Support @SHARECancerSupt
@StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: https://t.co/1PzUqaJ4Hd #gyncsm
Tobey @BRCAinfo
RT @womenofteal: T2 Carbo desensitization highlighted https://t.co/BRLcoQYs1S #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: @btrfly12 It has been growing in use for these two cancers - data are getting stronger now for all to offer - but still need to ask for it! #gyncsm
Dee Sparacio @womenofteal
@SHAREing @StephanieVBlank @NYULMC @SGO_org Great to know. Thanks! #gyncsm
Rick Boulay,MD @journeycancer
#Gyncsm Same with us Shannon. Totally agree. https://t.co/7BAeQD2v9t
Dee Sparacio @womenofteal
RT @SHAREing: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: https://t.co/1PzUqaJ4Hd #gyncsm
Christina Lizaso @btrfly12
RT @Stigetta: @btrfly12 Mechanics have been covered in the past, but this was the first I saw that also covered communication. Very powerful session! #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@subatomicdoc @btrfly12 No - and likely won't. Large observational studies changed practice in #vulvar ca - this will likely be the case for endo + cervix #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @ShannonWestin: @subatomicdoc @btrfly12 No - and likely won't. Large observational studies changed practice in #vulvar ca - this will likely be the case for endo + cervix #gyncsm
Christina Lizaso @btrfly12
MT @journeycancer Many are doing this as well and really see a difference in post op recovery. #gyncsm https://t.co/RxBE3x8iRF
Tobey @BRCAinfo
RT @SHAREing: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: https://t.co/1PzUqaJ4Hd #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
RT @ShannonWestin: @btrfly12 We have been using enhanced recovery for the last 2 yrs - it makes a huge difference for pt recovery! better #QOL and pain control #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: @btrfly12 We have been using enhanced recovery for the last 2 yrs - it makes a huge difference for pt recovery! better #QOL and pain control #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: @subatomicdoc @btrfly12 No - and likely won't. Large observational studies changed practice in #vulvar ca - this will likely be the case for endo + cervix #gyncsm
Annie Ellis @Stigetta
RT @SHAREing: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: @StephanieVBlank of @NYULMC will present the latest info on #ovariancancer from @SGO_org 's annual meeting: https://t.co/1PzUqaJ4Hd #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T3: What was the #Trials4GynCancerNow campaign which took part during the #SGOMtg? How does gyn cancer trial access impact care? #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @gyncsm: T3: T3: What was the #Trials4GynCancerNow campaign which took part during the #SGOMtg? How does gyn cancer trial access impact care? #gyncsm
Dee Sparacio @womenofteal
T3 Our #gyncsm blog post https://t.co/JvU8IHk3oi
Annie Ellis @Stigetta
T3: Fewer trials means slower progress. Also means less access to novel therapies for patients who have limited options. #gyncsm
Dee Sparacio @womenofteal
RT @thathealthsite @btrfly12 #gyncsm Patient psych outcomes as important as physical and cost outcomes... so for robotic surgery.
Shannon Westin, MD, MPH, FASCO @ShannonWestin
T3: Clinical trials change practice in #GynCancer - pts that participate get early access to new therapies - quicker progress #gyncsm
Shereese Maynard, MS; MBA 😷 She/Her @ShereeseMayMba
RT @womenofteal: T3 Our #gyncsm blog post https://t.co/JvU8IHk3oi
Christina Lizaso @btrfly12
T3: You can read the @SGO_org Fact Sheet on #Trials4GynCancerNow on the #gyncsm blog https://t.co/9G8FmzqkRE
Shannon Westin, MD, MPH, FASCO @ShannonWestin
This. #gyncsm https://t.co/9o7qJtKxPU
Christina Lizaso @btrfly12
RT @Stigetta: T3: T3: Fewer trials means slower progress. Also means less access to novel therapies for patients who have limited options. #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
@ShannonWestin @btrfly12 Many peeps are not aware of enhanced recovery programs. Need awareness with ⬆️ patient engagement to be initiated at consult phase #gyncsm
Dee Sparacio @womenofteal
MT @ShannonWestin T3: CT change practice in #GynCancer - pts participate get early access to new therapies - quicker progress #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: T3: T3: Clinical trials change practice in #GynCancer - pts that participate get early access to new therapies - quicker progress #gyncsm
Tobey @BRCAinfo
RT @btrfly12: T3: T3: You can read the @SGO_org Fact Sheet on #Trials4GynCancerNow on the #gyncsm blog https://t.co/9G8FmzqkRE
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@LguzzardiM @btrfly12 So true - our pts are becoming HUGE advocates for it! #gyncsm
Rick Boulay,MD @journeycancer
Yup. https://t.co/KtD0heHulG
Annie Ellis @Stigetta
RT @btrfly12: T3: T3: You can read the @SGO_org Fact Sheet on #Trials4GynCancerNow on the #gyncsm blog https://t.co/9G8FmzqkRE
GIS Sharer @GIS_Sharer
RT @thathealthsite:
Dee Sparacio @womenofteal
T3 restructuring cooperative groups impacted number too. #gyncsm
Alicia Giralt @GiraltAlicia
I've just been accepted to a clinical trial for ovarian cancer 2nd and 3rd recurrences. I hope I can contribute to the conversation #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Topic 4 (T4:) coming up. Then we'll have some time for everyone to pose questions. https://t.co/qZ7zBWS2To #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal This is a huge issue - #GynCancers are no longer the priority of the cooperative group #gyncsm
GYN Cancer | #GYNCSM @gyncsm
@GiraltAlicia welcome :) #gyncsm
Rick Boulay,MD @journeycancer
RT @womenofteal: T3 restructuring cooperative groups impacted number too. #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
@ShannonWestin @btrfly12 Fabulous to hear! No bigger or better advocate than the fully informed patient. #gyncsm
Rick Boulay,MD @journeycancer
RT @GiraltAlicia: I've just been accepted to a clinical trial for ovarian cancer 2nd and 3rd recurrences. I hope I can contribute to the conversation #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: T3: T3: Clinical trials change practice in #GynCancer - pts that participate get early access to new therapies - quicker progress #gyncsm
Christina Lizaso @btrfly12
@GiraltAlicia thanks so much - clinical trial participation is key to moving the science forward and impacting all #gyncsm
Rick Boulay,MD @journeycancer
#gyncsm Wishing you every success Alicia! https://t.co/jjLCEWaQRe
Dee Sparacio @womenofteal
T3 90% reduction in phase 3 clinical trial participation is startling to me. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@GiraltAlicia Great to hear! Welcome #gyncsm
Tobey @BRCAinfo
@GiraltAlicia Welcome Alicia. I'm glad you made it 💕 Good luck with the trials. Big clinical trial cheerleader here. #gyncsm
Alicia Giralt @GiraltAlicia
Thanks, everybody #gyncsm
Rick Boulay,MD @journeycancer
RT @ShannonWestin: @womenofteal This is a huge issue - #GynCancers are no longer the priority of the cooperative group #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal Directly related to the cooperative group issues - these trials are now required to be run by industry and may not be prioritized #gyncsm
Dee Sparacio @womenofteal
@ShannonWestin Same thing happened on the state level - county cancer coalitions became chronic disease coalitions #gyncsm
Rick Boulay,MD @journeycancer
RT @womenofteal: T3 90% reduction in phase 3 clinical trial participation is startling to me. #gyncsm
Annie Ellis @Stigetta
T3: Must read! Crisis in gym clinical trial funding: https://t.co/b4Vc6eS1K4 #gyncsm
Dee Sparacio @womenofteal
RT @Stigetta: T3: Must read! Crisis in gym clinical trial funding: T3: Must read! Crisis in gym clinical trial funding: https://t.co/b4Vc6eS1K4 #gyncsm
Rick Boulay,MD @journeycancer
#gyncsm YIKES! https://t.co/jLyqzO7H7u
Dee Sparacio @womenofteal
Mt @Stigetta T3:Crisis in gyn CT funding: https://t.co/L8Y6U5nbR5 #gyncsm
Christina Lizaso @btrfly12
BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T4: What was something you learned or were reminded of during #SGOMtg that you plan to implement or follow-up on? #gyncsm
Dee Sparacio @womenofteal
@ShannonWestin Not liking that. #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
Will try to be there! #gynscm https://t.co/FwEjF7Up9w
Dee Sparacio @womenofteal
RT @gyncsm: T4: T4: What was something you learned or were reminded of during #SGOMtg that you plan to implement or follow-up on? #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @gyncsm: T4: T4: What was something you learned or were reminded of during #SGOMtg that you plan to implement or follow-up on? #gyncsm
Christina Lizaso @btrfly12
RT @Stigetta: T3: Must read! Crisis in gym clinical trial funding: T3: Must read! Crisis in gym clinical trial funding: https://t.co/b4Vc6eS1K4 #gyncsm
Rick Boulay,MD @journeycancer
RT @btrfly12: BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
Tobey @BRCAinfo
RT @btrfly12: BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: T3 90% reduction in phase 3 clinical trial participation is startling to me. #gyncsm
Lisa M Guzzardi, RN @LguzzardiM
RT @btrfly12: BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
Christina Lizaso @btrfly12
RT @LguzzardiM: @ShannonWestin @btrfly12 Many peeps are not aware of enhanced recovery programs. Need awareness with ⬆️ patient engagement to be initiated at consult phase #gyncsm
Dee Sparacio @womenofteal
T4 earlier palliative care study was important for patients to hear as well as health care providers #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: T4 earlier palliative care study was important for patients to hear as well as health care providers #gyncsm
Zarifa Roberson 🇧🇸♍️ 💙💛🐩 @zarifaroberson
RT @gyncsm: T4: T4: What was something you learned or were reminded of during #SGOMtg that you plan to implement or follow-up on? #gyncsm
Rick Boulay,MD @journeycancer
RT @womenofteal: T4 earlier palliative care study was important for patients to hear as well as health care providers #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
This has been shown in multiple cancer types - earlier palliative care involvement yields better outcomes #gyncsm https://t.co/g0oaSD9tn0
Christina Lizaso @btrfly12
@womenofteal I hope that keeps gaining momentum. Keep reading of families where palliative care offered so late. Should be at start #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: This has been shown in multiple cancer types - earlier palliative care involvement yields better outcomes #gyncsm https://t.co/g0oaSD9tn0
Annie Ellis @Stigetta
RT @btrfly12: BTW - Hope you all can join me for a #CTAW2017 (Clinical Trials Awareness Week) chat on Tue May 5th at 1pmET https://t.co/23WTBLI1HN #gyncsm
Annie Ellis @Stigetta
RT @womenofteal: T4 earlier palliative care study was important for patients to hear as well as health care providers #gyncsm
Sheryl Pasquinelli @slpasky94
@christina Lizaso why palliative care at start? #gyncsm
Christina Lizaso @btrfly12
T4: I was reminded that while nothing seemed "breakthrough" or "earth shattering" that progress is being made. #gyncsm
Annie Ellis @Stigetta
@womenofteal I think all gyn patients should have palliative care team at diagnosis for symptom mgmt. better compliance, QoL and outcomes #gyncsm
Dee Sparacio @womenofteal
@btrfly12 Agree . So many areas - targeted therapy, immunotherapy, patient reported outcomes, #gyncsm
Rick Boulay,MD @journeycancer
#gyncsm We tried that in Ovarian cancer and the message got too confusing: cure vs palliation. https://t.co/x6Ij2PJJTb
Annie Ellis @Stigetta
RT @ShannonWestin: This has been shown in multiple cancer types - earlier palliative care involvement yields better outcomes #gyncsm https://t.co/g0oaSD9tn0
Christina Lizaso @btrfly12
@slpasky94 palliative (or supportive) care is valuable in dealing w/ side effects of cancer and treatment no matter where in journey #gyncsm
Rick Boulay,MD @journeycancer
RT @womenofteal: @btrfly12 Agree . So many areas - targeted therapy, immunotherapy, patient reported outcomes, #gyncsm
Alicia Giralt @GiraltAlicia
I thought palliative care was for the last months of life. Am I wrong? #gyncsm
Robin Martinez @RobinSmrtPtient
Many think palliative care means giving up on curative care. Hard to overcome that misconception. #gyncsm
Christina Lizaso @btrfly12
@journeycancer it is tough because so much misunderstanding about what palliative care is - term just confuses more #gyncsm
Rick Boulay,MD @journeycancer
I think next year will be the immunoocology Year. #gyncsm
Dee Sparacio @womenofteal
@GiraltAlicia that is Hospice care #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: @subatomicdoc @btrfly12 No - and likely won't. Large observational studies changed practice in #vulvar ca - this will likely be the case for endo + cervix #gyncsm
Annie Ellis @Stigetta
T4: need more dialogue. Too many ppl believe palliative = hospice. Not true!! So many benefits to early supportive care #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@RobinSmrtPtient This is a huge stigma that is hard to overcome - both for pts and providers! #gyncsm
Alicia Giralt @GiraltAlicia
I thought they were the same. What's the difference? #gyncsm
Christina Lizaso @btrfly12
There are great palliative care specialists that have a lot to offer way before hospice and even when hospice not anticipated #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @gyncsm: T4: T4: What was something you learned or were reminded of during #SGOMtg that you plan to implement or follow-up on? #gyncsm
Dee Sparacio @womenofteal
This RT @Stigetta T4: need more dialogue. Too many ppl believe palliative = hospice. Not true!! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: @womenofteal Directly related to the cooperative group issues - these trials are now required to be run by industry and may not be prioritized #gyncsm
Sheryl Pasquinelli @slpasky94
T4: What would Pallative care offer above my oncology care team. #gyncsm
Tobey @BRCAinfo
@journeycancer I truly hope so #immunotherapy #gyncsm 🙏
GYN Cancer | #GYNCSM @gyncsm
We kind already into out last topic area :) #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@GiraltAlicia They can provide early symptom control and maximize #QOL for all patients - also mental health support! #gyncsm
GYN Cancer | #GYNCSM @gyncsm
T5: For our last topic, we'll let our participants ask questions they have about gynecologic cancer research. #gyncsm
Annie Ellis @Stigetta
RT @btrfly12: There are great palliative care specialists that have a lot to offer way before hospice and even when hospice not anticipated #gyncsm
Rick Boulay,MD @journeycancer
RT @Stigetta: T4: T4: need more dialogue. Too many ppl believe palliative = hospice. Not true!! So many benefits to early supportive care #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @slpasky94: T4: T4: What would Pallative care offer above my oncology care team. #gyncsm
Christina Lizaso @btrfly12
Here's info from the #gyncsm chat we had on Palliative Care with links to learn more: https://t.co/zf4XuaIJYy
Dee Sparacio @womenofteal
RT @gyncsm: T5: T5: For our last topic, we'll let our participants ask questions they have about gynecologic cancer research. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Here's info from the #gyncsm chat we had on Palliative Care with links to learn more: Here's info from the #gyncsm chat we had on Palliative Care with links to learn more: https://t.co/zf4XuaIJYy
Alicia Giralt @GiraltAlicia
This information is very valuable to me. Thanks! #gyncsm
Robin Martinez @RobinSmrtPtient
@thathealthsite, yes, we need a new term because in some countries palliative care DOES mean end of life. #gyncsm
Sheryl Pasquinelli @slpasky94
@btrfly12 Thank you. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Here's info from the #gyncsm chat we had on Palliative Care with links to learn more: https://t.co/qtWoP1n1dQ
Matthew Katz, MD 🟦 @subatomicdoc
@slpasky94 Excellent question! Differs by disease and person, but pallative care focuses on quality of life, while ...#gyncsm
Christina Lizaso @btrfly12
There is also #hpm (hospice and palliative medicine) chat which takes place Wednesdays at 9pmET - so that one is happening now :) #gyncsm
Dee Sparacio @womenofteal
RT @gyncsm: T5: For our last topic, we'll let our participants ask questions they have about gynecologic cancer research. #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: @GiraltAlicia They can provide early symptom control and maximize #QOL for all patients - also mental health support! #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@RobinSmrtPtient @thathealthsite Our group calls themselves Supportive Care to help with this issue #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@slpasky94 ...medical oncology does that but also strong priority on cancer control. Sometimes two goals are at odds #gyncsm
Dee Sparacio @womenofteal
Good chat RT @btrfly12: There is also #hpm (hospice and palliative medicine) chat which takes place Wednesdays at 9pmET #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@slpasky94 Sometimes its just additional time and focus on side effects and symptoms that your oncology care team may not have - #gyncsm
Christina Lizaso @btrfly12
If you haven't read @womenofteal 's latest blog post about NIH funding for cancer research, have a look https://t.co/BHJD6KlO65 #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @womenofteal: Good chat RT @btrfly12: Good chat RT @btrfly12: There is also #hpm (hospice and palliative medicine) chat which takes place Wednesdays at 9pmET #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: @RobinSmrtPtient @thathealthsite Our group calls themselves Supportive Care to help with this issue #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @btrfly12: If you haven't read @womenofteal 's latest blog post about NIH funding for cancer research, have a look https://t.co/BHJD6KlO65 #gyncsm
Christina Lizaso @btrfly12
T5: I'm wondering what the mood was like about the future of cancer research funding and the cancer moonshoot initiative #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @btrfly12: If you haven't read @womenofteal 's latest blog post about NIH funding for cancer research, have a look https://t.co/BHJD6KlO65 #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @ShannonWestin: @slpasky94 Sometimes its just additional time and focus on side effects and symptoms that your oncology care team may not have - #gyncsm
Rick Boulay,MD @journeycancer
RT @btrfly12: If you haven't read @womenofteal 's latest blog post about NIH funding for cancer research, have a look https://t.co/BHJD6KlO65 #gyncsm
Cancer Research News @CancerNewsApp
RT @gyncsm: T5: T5: For our last topic, we'll let our participants ask questions they have about gynecologic cancer research. #gyncsm
Christina Lizaso @btrfly12
T5: Also, what do you want to see research resources focused on? what are some gaps in research? #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @btrfly12: T5: T5: Also, what do you want to see research resources focused on? what are some gaps in research? #gyncsm
Sheryl Pasquinelli @slpasky94
T5: Is there any exciting research for Platinum resistant cancer? #gyncsm
Dee Sparacio @womenofteal
RT @slpasky94: T5: T5: Is there any exciting research for Platinum resistant cancer? #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@btrfly12 There is a big push 4 pt reported outcomes - a great way to measure impact on #QOL - especially when drugs have similar outcomes #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: @btrfly12 Agree . So many areas - targeted therapy, immunotherapy, patient reported outcomes, #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@btrfly12 T5: I'd like to see more resources dedicate to ensuring current research can be more easily implemented in practice #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: @btrfly12 There is a big push 4 pt reported outcomes - a great way to measure impact on #QOL - especially when drugs have similar outcomes #gyncsm
Annie Ellis @Stigetta
RT @btrfly12: If you haven't read @womenofteal 's latest blog post about NIH funding for cancer research, have a look https://t.co/BHJD6KlO65 #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: @slpasky94 Sometimes its just additional time and focus on side effects and symptoms that your oncology care team may not have - #gyncsm
Annie Ellis @Stigetta
RT @ShannonWestin: @btrfly12 There is a big push 4 pt reported outcomes - a great way to measure impact on #QOL - especially when drugs have similar outcomes #gyncsm
Christina Lizaso @btrfly12
RT @subatomicdoc: @btrfly12 T5: @btrfly12 T5: I'd like to see more resources dedicate to ensuring current research can be more easily implemented in practice #gyncsm
Dee Sparacio @womenofteal
T5 Can search the abstract for info https://t.co/O7EjLiostG #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@btrfly12 I think there is a huge prioritization for cancer research in certain circles - will need to see if it is supported in our gov't #gyncsm
Christina Lizaso @btrfly12
@thathealthsite I tend to see studies like that coming out of Oncology Nursing Society ONS #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@btrfly12 Pardon me - dedicated. #gyncsm
Dee Sparacio @womenofteal
T5 I know the young researchers at my NCI Comprehensive Ca center were worried about support. #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @womenofteal: T5 Can search the abstract for info https://t.co/O7EjLiostG #gyncsm
Annie Ellis @Stigetta
T5: So many approved PARPi for treatment and maintenance, is there a preferred order of use? What do we know about serial PARPi S/Es?#gyncsm
Christina Lizaso @btrfly12
@thathealthsite I think there was some mindfulness research recently - trying to remember if was breast cancer or other... #gyncsm
Rick Boulay,MD @journeycancer
T5. I'd like to see research focused on the genomics and treatment of rare tumors like Gyn Malignancies. #gyncsm
Christina Lizaso @btrfly12
RT @ShannonWestin: @btrfly12 I think there is a huge prioritization for cancer research in certain circles - will need to see if it is supported in our gov't #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@Stigetta These are questions that we need to answer- there are a few differences in first use side effects - we don't know about serial #gyncsm
Rick Boulay,MD @journeycancer
RT @subatomicdoc: @btrfly12 T5: @btrfly12 T5: I'd like to see more resources dedicate to ensuring current research can be more easily implemented in practice #gyncsm
Dee Sparacio @womenofteal
@btrfly12 Thanks. Good to help get the word out. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Time to start sharing closing thoughts on our #SGOMtg recap. We like to start the tweets with “TIL:” standing for Today I Learned #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Feel free to also keep discussing topics that have come up. #gyncsm
Rick Boulay,MD @journeycancer
RT @gyncsm: Time to start sharing closing thoughts on our #SGOMtg recap. We like to start the tweets with “TIL:” standing for Today I Learned #gyncsm
Dee Sparacio @womenofteal
Wondered the same thing. https://t.co/OeNDPu9RlV
GYN Cancer | #GYNCSM @gyncsm
Thanks to everyone for tonight's discussion. The next #gyncsm chat is Wed May 10 at 9pmET on Womanhood, Femininity and Cancer.
Shannon Westin, MD, MPH, FASCO @ShannonWestin
RT @gyncsm: Thanks to everyone for tonight's discussion. The next #gyncsm chat is Wed May 10 at 9pmET on Womanhood, Femininity and Cancer.
Tobey @BRCAinfo
movie 'Living Proof" or book: Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - story re research & $$$ #gyncsm
Sheryl Pasquinelli @slpasky94
TIL that there are doctors who will take their personal time to interact with patients. Thank you! #gyncsm
Rick Boulay,MD @journeycancer
TIL The cancer research race is won by the tortoise, progressive benefits stacked upon each other. #gyncsm https://t.co/0nZUfIyTUL
Dee Sparacio @womenofteal
RT @gyncsm: Thanks to everyone for tonight's discussion. The next #gyncsm chat is Wed May 10 at 9pmET on Womanhood, Femininity and Cancer.
GYN Cancer | #GYNCSM @gyncsm
RT @slpasky94: TIL that there are doctors who will take their personal time to interact with patients. Thank you! #gyncsm
Tobey @BRCAinfo
@womenofteal @ShannonWestin @btrfly12 @journeycancer 🙏💕 thank you for all you do #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @thathealthsite:
Alicia Giralt @GiraltAlicia
#gyncsm TIL palliative care and hospice are different things.
Rick Boulay,MD @journeycancer
RT @gyncsm: Thanks to everyone for tonight's discussion. The next #gyncsm chat is Wed May 10 at 9pmET on Womanhood, Femininity and Cancer.
Annie Ellis @Stigetta
@journeycancer Important area! Understudied! #gyncsm
Dee Sparacio @womenofteal
Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte
Rick Boulay,MD @journeycancer
@slpasky94 It's a passion we all share #gyncsm
GYN Cancer | #GYNCSM @gyncsm
RT @journeycancer: TIL The cancer research race is won by the tortoise, progressive benefits stacked upon each other. #gyncsm https://t.co/0nZUfIyTUL
GYN Cancer | #GYNCSM @gyncsm
Remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats.
Annie Ellis @Stigetta
RT @womenofteal: Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @DrMarkham @journeycancer @DrBeckerSchutte
GYN Cancer | #GYNCSM @gyncsm
Patients and caregivers are invited to continue our discussion on the Smart Patients platform at https://t.co/dFCf1Mcahw #gyncsm
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@slpasky94 you are welcome! Great to meet you!! #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @gyncsm: Remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats.
Dee Sparacio @womenofteal
RT @gyncsm: Remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats.
Shannon Westin, MD, MPH, FASCO @ShannonWestin
@womenofteal @btrfly12 @DrMarkham @journeycancer @DrBeckerSchutte Thank you Dee and Christina!!! #gyncsm
Dee Sparacio @womenofteal
@slpasky94 thanks for join us. Feel free to use #gyncsm if you have other questions.
Christina Lizaso @btrfly12
Good to see some research on rarer gyn cancers like this one on Vulvar cancer https://t.co/jTCQC18Boy #gyncsm
Dee Sparacio @womenofteal
Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm
Rebekah Moore, MS, CGC (she/her) @GeneticsRebekah
RT @NCICancerStats: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: Genetic testing and counseling is recommended for women with a family history of certain cancers. More here: https://t.co/uWYdgxjsqY #GynCSM
Christina Lizaso @btrfly12
Past #SGOMtg Research Recap #gyncsm chats: 2014 https://t.co/wUiAM3hp9K 2015 https://t.co/w1ZwfH1xQH and 2016 https://t.co/5sqJnrCGNY
Annie Ellis @Stigetta
RT @womenofteal: Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources #gyncsm
Rick Boulay,MD @journeycancer
Have a good. Ivette everyone. See you next month. #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
RT @btrfly12: Past #SGOMtg Research Recap #gyncsm chats: Past #SGOMtg Research Recap #gyncsm chats: 2014 https://t.co/wUiAM3hp9K 2015 https://t.co/w1ZwfH1xQH and 2016 https://t.co/5sqJnrCGNY
Dee Sparacio @womenofteal
technology did not want to cooperate today. First during a phone meeting and now - I think I missed tweets. #gyncsm
GYN Cancer | #GYNCSM @gyncsm
Thanks again all. Have a great evening and hope to see you at our May chat. #gyncsm
Dee Sparacio @womenofteal
@journeycancer Thanks Rick - see you next month #gyncsm
Dee Sparacio @womenofteal
Thanks everyone for joining us. #gyncsm
Dee Sparacio @womenofteal
RT @btrfly12: Good to see some research on rarer gyn cancers like this one on Vulvar cancer https://t.co/jTCQC18Boy #gyncsm
Annie Ellis @Stigetta
TIL: so much more gyn research needed. Fewer research $$$ available for trials. Unacceptable! #gyncsm
Dee Sparacio @womenofteal
Cancer Network Conference - Selected Study Summaries https://t.co/mNgKMLYcOj #gyncsm
Christina Lizaso @btrfly12
[ hmm.... I think @tchatio may be missing some tweets due to @twitter new reply settings... ] #gyncsm
Dee Sparacio @womenofteal
Foundation for Womens Cancer: Closer Look 2min https://t.co/hHcyaoyNtE #gyncsm
Christina Lizaso @btrfly12
RT @Stigetta: TIL: TIL: so much more gyn research needed. Fewer research $$$ available for trials. Unacceptable! #gyncsm
Christina Lizaso @btrfly12
@Stigetta Thanks so much for joining the chat. #gyncsm
Christina Lizaso @btrfly12
RT @womenofteal: Foundation for Womens Cancer: Foundation for Womens Cancer: Closer Look 2min https://t.co/hHcyaoyNtE #gyncsm
Dee Sparacio @womenofteal
@btrfly12 @tchatio @Twitter Yes that has been happening. I did better following on Twitter in search. #gyncsm
Dee Sparacio @womenofteal
@Stigetta Appreciate you join tonight and thanks for the great tweets from #SGOmtg. Felt like I was there. Are you going to ASCO? #gyncsm
Matthew Katz, MD 🟦 @subatomicdoc
@womenofteal Thank you and @btrfly12 for coordinating+moderating! Have a great night, everyone :-) #gyncsm
Christina Lizaso @btrfly12
@subatomicdoc great to chat with you again :) Thanks for all you do. #gyncsm
Christopher Donley @onehandedpotter
RT @womenofteal: T5 Can search the abstract for info https://t.co/O7EjLiostG #gyncsm
Christina Lizaso @btrfly12
There are also tweet summaries from #SGOMtg available on @womenofteal 's blog https://t.co/x79HJYGYsk - See March 2017 posts #gyncsm
Wafik S. El-Deiry, MD, PhD, FACP @weldeiry
The latest The Cancer Plus Daily! https://t.co/fjQEPsiOW0 Thanks to @StuckonSW @NatRevUrol @DrBetofMDPhD #gyncsm #ehealth
#GynCSM content from Twitter.